Asterand plc, the human tissue bank located in Detroit's TechTown, has
entered into a three-year collaboration with Bristol-Myers Squibb in
which Asterand will provide the pharmaceutical giant with drug
discovery services and clinical samples.
Excerpt:
"This decision by Bristol-Myers Squibb is an important validation of Asterand’s products and services," said Asterand CEO Martyn Coombs. "Our goal is to assist Bristol-Myers Squibb and other pharmaceutical companies in making the drug development process more effective and we want to help them reach the clinic with less cost and more confidence. We are particularly proud that Bristol-Myers Squibb has renewed its relationship with Asterand because of the importance they place on collaborating with highly qualified research partners."
Read the entire article
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.